Get started
Author

Alli Murugesan

ORCID: 0000-0002-0920-7732
Observed ORCID: 0000-0002-0920-7732
OpenAlex ID: A5047072597
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191
2015 · Annette E. Hay, Alli Murugesan, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 38
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis
2020 · Alli Murugesan, Grégoire Lassalle-Claux, et al. · Journal of Natural Products · 18
Evaluation of a Low-Threshold/High-Tolerance Methadone Maintenance Treatment Clinic in Saint John, New Brunswick, Canada: One Year Retention Rate and Illicit Drug Use
2012 · Timothy K. S. Christie, Alli Murugesan, et al. · Journal of Addiction · 18
PDF
Anti-hyperglycemic activity of HPLC-fractionated Momordica charantia seed extract enriched in a novel napin-like protein in experimental diabetic rats and its validation with recombinant napin-like protein
2022 · Alli Murugesan, Shailesh Kumar R. Yadav, et al. · Current Research in Biotechnology · 15
PDF
Nanoparticle Surface-Enhanced Raman Spectroscopy as A Noninvasive, Label-Free Tool to Monitor Hematological Malignancy
2021 · Stacy Grieve, Nagaprasad Puvvada, et al. · Nanomedicine · 14
PDF
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10
2020 · Stacy Grieve, Keyue Ding, et al. · ESMO Open · 7
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma
2016 · Ming Han, Alli Murugesan, et al. · Blood · 4
Cell-Free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma
2024 · Dor D. Abelman, Jenna Eagles, et al. · Blood · 3
Cell-Free DNA from Blood or Bone Marrow as Alternatives to Bone Marrow Cells for Molecular Diagnostics and Monitoring of Multiple Myeloma
2023 · Dor D. Abelman, Jenna Eagles, et al. · Blood · 3
Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple Myeloma
2025 · Dor D. Abelman, Jenna Eagles, et al. · medRxiv · 1
A Phase II Study of AT9283, an Aurora Kinase Inhibitor, in Patients with Relapased or Refractory Multiple Myloma; NCIC Clinical Trials Group IND.191
2014 · Annette E Hay, Alli Murugesan, et al. · Blood · 1
Accurate prediction of breast cancer gene BRCA1 domain ligands with potential drugs via Homology modeling
2011 · Alli Murugesan, S. Sasi premila, et al. · Journal of computational methods in molecular design · 1
Matched marrow and blood profiling reveals compartment- and feature-specific liquid-biopsy signals in multiple myeloma
2026 · Dor D. Abelman, Jenna Eagles, et al. · medRxiv
cfDNA WGS vs plasma proteomics for minimally invasive MRD assessment in multiple myeloma.
2026 · Dor Abelman, Aimee Wong, et al. · Journal of Clinical Oncology
Abstract 2597: Baseline cfDNA fragmentomics identifies multiple myeloma patients at risk of early progression
2026 · Dor David Abelman, Jenna Eagles, et al. · Cancer Research
Ultra-Deep, Cost-Efficient Whole-Genome Sequencing of Cell Free DNA Recovers Most Bone Marrow Mutations in Newly Diagnosed Multiple Myeloma
2025 · Dor Abelman, David Scott, et al. · Clinical Lymphoma Myeloma & Leukemia
Abstract 3250: Tumor-independent monitoring of minimal residual disease in multiple myeloma using cfDNA fragmentomics
2025 · Dor D. Abelman, Jenna Eagles, et al. · Cancer Research
P-162 Cell-free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma
2024 · Dor Abelman, Jenna Eagles, et al. · Clinical Lymphoma Myeloma & Leukemia
P081: Enhancing minimally invasive minimal residual disease detection of multiple myeloma using cell-free DNA whole-genome sequencing
2024 · Dor Abelman, Madhuran Thiagarajah, et al. · Genetics in Medicine Open
Abstract 6559: Novel anti-myeloma potential of CAPE analogs: Downregulation of IKZF1-IRF4-MYC axis
2020 · Alli Murugesan, Gregoire Lasalle-Claux, et al. · Cancer Research
Abstract 3791: TRPV6 calcium channel peptide antagonists as novel antimyeloma and antiresorptive agents
2016 · Alli Murugesan, Philippe Tremblay, et al. · Cancer Research
Abstract 3405: The analysis of TRPV6 expression in lymphoid tumours
2016 · Ashley M. DiPasquale, Tarek Rahmeh, et al. · Cancer Research
A Pharmacogenetic Study of the NCIC CTG Clinical Trial My.10: Single Nucleotide Polymorphisms, Prognosis, and Predicting Benefit from IMiD® Compound Maintenance Therapy Following Autologous Stem Cell Transplant for Multiple Myeloma
2015 · Ming Han, Alli Murugesan, et al. · Blood
Works count: 23
Citation count: 123
H-index: 6
I10-index: 5
Year
Topic
Type